Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

RomaniaBack to Romania

Clinical trials in Călărași

3 clinical trials in Călărași, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.

RomaniaOur site in RomaniaStudii.Clinice.ro(opens in a new tab)
Călărași at a glance
3
clinical trials
  • Not yet recruiting0
  • Research sites0
Type of trial
Recruitment status
Quick filters

3 trials in Călărași

Open in trial search

Varicella

Recruiting

Study of new chickenpox vaccine and measles-mumps-rubella vaccine given by intramuscular injection in healthy children aged 12 to 15 months

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:0–17 years · Healthy volunteers
  • Substances:GSKVX000000025896
  • Sponsor:GlaxoSmithKline Biologicals

Influenza

Not recruiting

Study on the Effectiveness of an MF59-Adjuvanted Influenza Vaccine Compared to a Non-Adjuvanted Vaccine in Adults Aged 65 and Older

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:65+ years · Healthy volunteers
  • Substances:A/DARWIN/9/2021 (H3N2) - LIKE STRAIN (A/DARWIN/6/2021, IVR-227)
  • Sponsor:Seqirus UK Limited

Meningococcal infection

Not recruiting

Study on the Safety and Immune Response of MenACYW Conjugate Vaccine Compared to a Drug Combination in Healthy Infants and Toddlers

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:0–17 years · Healthy volunteers
  • Substances:N. Meningitidis Group C (Strain C11) Polysaccharide (De-O-Acetylated) Conjugated To Tetanus Toxoid
  • Sponsor:Sanofi Pasteur

Other cities in Romania

The busiest research cities in the country

All 65 cities in Romania

Clinical research in Călărași

What the registry says about research in the country

01 Meningococcal Research

Clinical trials focusing on meningococcal infection prevention in young children, evaluating a new conjugate vaccine's effectiveness against multiple serogroups.

  • Vaccine immunogenicity assessment
  • Infant and toddler safety studies
  • Serogroup protection analysis

The research aims to advance protection against various meningococcal strains through a specialized vaccination schedule.

02 Influenza Studies

Investigation of an innovative MF59-adjuvanted influenza vaccine designed specifically for elderly populations aged 65 and above.

  • Vaccine efficacy evaluation
  • Safety profile assessment
  • Immune response monitoring

This research compares adjuvanted and non-adjuvanted vaccines to enhance protection against various influenza strains in older adults.

Back to RomaniaAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.